Anthropic CEO Dario Amodei responded to criticism that his warnings about AI risks have fueled negative public sentiment and regulatory backlash in the U.S. He argued his messaging has been balanced between AI's risks and benefits, emphasizing that public distrust stems from a long-standing crisis of trust in tech companies rather than his warnings alone. Amodei acknowledged the public's negative view of AI is a problem but stressed that AI companies, including Anthropic, have yet to fully deliver on their promises to benefit society. On regulation, he rejected the notion that it necessarily concentrates power, stating Anthropic supports policies that slow down frontier AI firms while helping smaller competitors.
1606 Corp. has signed a non-binding Letter of Intent (LOI) with EthosEnergy O&M to manage operations and maintenance of its planned 55 MW power facility in Lufkin, Texas, aimed at supporting data centers and AI applications. EthosEnergy O&M brings ex...
Adia Med has verified it has 361 round-lot shareholders, exceeding Nasdaq Capital Market's minimum requirement of 300 for an initial listing. This milestone is part of Adia Med's ongoing efforts to meet Nasdaq's listing standards, though other criter...
Québec Innovative Materials Corp. (QIMC) has started two large-scale, non-invasive 2D seismic surveys totaling about 78 line-kilometres to explore natural hydrogen in Québec and Nova Scotia. The 36 km survey in Québec is in partnership with the Témis...
Innovative Eyewear has formed an exclusive distribution partnership with Directed Electronics to market its Lucyd and Reebok smart eyewear products in Australia and New Zealand. Directed Electronics brings over 20 years of experience in consumer elec...
Lexaria Bioscience Corp. announced the exercise of warrants for 453,969 shares at a reduced price of $12.92 per share, raising approximately $5.9 million in gross proceeds. The funds will support the company's working capital and general corporate pu...
